ArticleScientific reports2023

The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA).

Lorenzo Blasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.